Breaking News
Get 50% Off 0
Nederlandse versie beschikbaar
Wilt u liever naar Investing.com's Nederlandse editie?
🧠 Smart money is quietly buying these undervalued gems
See Undervalued Stocks
Close

IO Biotech Inc (IOBTQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.007 -0.001    -12.99%
15:59:59 - Closed. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 2,232,042
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.007 - 0.009
IO Biotech 0.007 -0.001 -12.99%

IOBTQ Recent Sentiments

 
This page contains information on users’ sentiments for the IO Biotech Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 09, 2026 Moshe Kazav   0.013 -46.15%
Apr 08, 2026 Angel Alexander Gima...   0.052 Apr 13, 2026 @ 0.011 -78.85%
Apr 06, 2026 dh sul   0.033 +78.79%
Apr 02, 2026 salvatore testai   0.031 +77.42%
Apr 02, 2026 Ali Kareeri   0.034 -79.41%
Apr 02, 2026 OneNPC That   0.048 Apr 06, 2026 @ 0.033 -31.25%
Mar 31, 2026 Sam Khetta   0.045 -84.44%
Mar 31, 2026 john kelly   0.046 -84.78%
Mar 31, 2026 Narciso Junior   0.042 -83.33%
Mar 31, 2026 zoltán penderik   0.060 Apr 06, 2026 @ 0.033 -45.00%
Mar 31, 2026 yato ha   0.173 Apr 06, 2026 @ 0.033 +80.92%
Mar 20, 2026 zoltán penderik   0.179 Mar 23, 2026 @ 0.187 +4.47%
Mar 16, 2026 OneNPC That   0.195 Mar 23, 2026 @ 0.187 -4.10%
Mar 16, 2026 Simone Pivato   0.204 Mar 16, 2026 @ 0.167 -18.14%
Mar 16, 2026 jean charles marras   0.204 Mar 16, 2026 @ 0.167 -18.14%
Mar 10, 2026 Топ 4   0.278 Apr 01, 2026 @ 0.044 -84.17%
Mar 06, 2026 Aun Bukhari   0.307 Mar 27, 2026 @ 0.193 -37.13%
Mar 02, 2026 yato ha   0.321 Mar 09, 2026 @ 0.296 -7.79%
Feb 16, 2026 jean charles marras   0.370 Feb 23, 2026 @ 0.337 -8.92%
Feb 16, 2026 Jose Magavilla   0.370 Feb 23, 2026 @ 0.337 -8.92%
Feb 09, 2026 خليفه بن طمروق   0.387 Mar 06, 2026 @ 0.307 -20.67%
Feb 05, 2026 Jose Magavilla   0.298 Feb 09, 2026 @ 0.367 +23.15%
Feb 04, 2026 bruno angelico   0.279 Feb 27, 2026 @ 0.345 +23.66%
Jan 27, 2026 Wael Abdullah   0.318 Feb 20, 2026 @ 0.340 -6.92%
Jan 26, 2026 yato ha   0.353 Jan 26, 2026 @ 0.329 +6.80%
Jan 23, 2026 Vitor Ferreira   0.375 Feb 13, 2026 @ 0.370 +1.33%
Jan 23, 2026 Mücahit Aslan   0.257 Jan 26, 2026 @ 0.329 +28.02%
Jan 22, 2026 Arun Kavumpuram...   0.562 Feb 13, 2026 @ 0.370 -34.16%
Jan 22, 2026 Guirane Seck   0.463 Feb 13, 2026 @ 0.370 -20.09%
Jan 22, 2026 Andrea Puntaloro   0.435 Feb 13, 2026 @ 0.370 -14.94%
Jan 22, 2026 พฤษภา ภูมิไชย   0.436 Feb 13, 2026 @ 0.370 -15.14%
Jan 22, 2026 Jan Boczniewicz   0.352 Feb 13, 2026 @ 0.370 +5.11%
Jan 22, 2026 Didier Lonchant   0.356 Feb 13, 2026 @ 0.370 +3.93%
Jan 22, 2026 Enea Magni   0.403 Feb 13, 2026 @ 0.370 +8.19%
Jan 22, 2026 mauro maranco   0.281 Jan 26, 2026 @ 0.329 +17.08%
Jan 22, 2026 Leonardo Fontanot   0.257 Jan 26, 2026 @ 0.329 +28.02%
Jan 22, 2026 Alex Meloncon   0.251 Jan 26, 2026 @ 0.329 +31.08%
Jan 21, 2026 Топ 4   0.210 Jan 22, 2026 @ 0.461 +119.52%
Jan 21, 2026 Jaime Gonçalves   0.211 Feb 13, 2026 @ 0.370 -75.36%
Jan 21, 2026 Abdelmalik Ahmed Amar   0.211 Feb 13, 2026 @ 0.370 +75.36%
Jan 21, 2026 Simone Bartalesi   0.230 Feb 13, 2026 @ 0.370 +60.87%
Jan 12, 2026 Jose Magavilla   0.539 Jan 19, 2026 @ 0.502 -6.86%
Jan 08, 2026 Jose Magavilla   0.615 Jan 12, 2026 @ 0.537 -12.68%
Jan 05, 2026 ANDRÉS CAVERO...   0.650 Jan 12, 2026 @ 0.537 -17.38%
Dec 23, 2025 Invictus Invictus   0.730 Dec 29, 2025 @ 0.656 -10.14%
Dec 19, 2025 Ahmad Alnatour   0.638 Dec 19, 2025 @ 0.638 0.00%
Dec 17, 2025 Ciro Cangiano   0.661 Dec 22, 2025 @ 0.687 -3.93%
Dec 09, 2025 Rpb c   0.752 Dec 15, 2025 @ 0.737 -1.99%
Dec 04, 2025 A M   0.690 Dec 08, 2025 @ 0.714 +3.48%
Dec 04, 2025 Jose Magavilla   0.669 Dec 08, 2025 @ 0.714 +6.73%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IOBTQ Comments

Write your thoughts about IO Biotech Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rui Haddad
Rui Haddad Sep 08, 2025 1:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up up up
mubarak mousa
mubarak mousa Aug 12, 2025 12:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email